Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
FDA approves Lilly's EBGLYSS® (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
10 Jun 2026
PR Newswire Association LLC.
Lynk Pharmaceuticals' Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor
10 Jun 2026
PR Newswire Association LLC.
Pacira BioSciences Announces Stockholders Have Elected All Three of the Company's Director Nominees at Annual Meeting
09 Jun 2026
PR Newswire Association LLC.
Allergy/Immunology Leaders Unite to Strengthen the Specialty Workforce and Expand Access to High Quality Care
09 Jun 2026
PR Newswire Association LLC.
GMJ Technologies Appoints Carol Berry, MBA as New Chief Executive Officer
09 Jun 2026
PR Newswire Association LLC.
The Neighborhood Christian Clinic Receives $48,000 Grant from Thunderbirds Charities to Strengthen Clinical Operations, Security, and Continuity of Care
09 Jun 2026
PR Newswire Association LLC.
Pillr Health Acquires Cooper Strategy to Deepen Pharmacy Support for U.S. Hospitals and Health Systems
09 Jun 2026
GlobeNewswire
BioStem Technologies Announces Appointment of Three New Members to its Board of Directors
09 Jun 2026
PR Newswire Association LLC.
PDA Announces Glenn E. Wright is Stepping Down as CEO & President on June 30, 2026; Craig Elliott Assuming Role Effective July 1, 2026
09 Jun 2026
GlobeNewswire
Kymera Therapeutics Announces First Participant Dosed in Phase 1 Trial of Oral IRAK4 Degrader, KT-485, and Milestone Achievement Under Sanofi Collaboration
09 Jun 2026
PR Newswire Association LLC.
Color Health Partners with Priority Health to Expand Access to Color's Virtual Cancer Clinic
09 Jun 2026
GlobeNewswire
Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL
09 Jun 2026
GlobeNewswire
Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine Co-Admini
09 Jun 2026
GlobeNewswire
Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN
09 Jun 2026
PR Newswire Association LLC.
SignatureCare Emergency Center Opens New 24 Hour Emergency Room in Plano, TX
09 Jun 2026
PR Newswire Association LLC.
RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation
09 Jun 2026
GlobeNewswire
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09 Jun 2026
PR Newswire Association LLC.
Partillion Bioscience Showcases Nanovials as a Leading Platform for Cellular Interaction Analysis at CYTO 2026
09 Jun 2026
GlobeNewswire
Atavistik Bio Announces U.S. FDA Clearance of Investigational New Drug Application and Fast Track Designation for ATV-1601 for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)
09 Jun 2026
PR Newswire Association LLC.
Matricelf Advances Toward First in Human Trial with Initiation of GMP Manufacturing Program
09 Jun 2026
GlobeNewswire
BPGbio Appoints Renowned Neuroscientist Eric J. Nestler, M.D., Ph.D., as Chair of Scientific Advisory Board
09 Jun 2026
GlobeNewswire
iMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress
09 Jun 2026
GlobeNewswire
Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases
09 Jun 2026
PR Newswire Association LLC.
Evogene to Present Its Pharma Division Achievements at the BIO International Convention
09 Jun 2026
Latest News All News
Upcoming Events All Events
- June 2026
- San Diego: RESI San Diego 2026
- San Diego: BIO 2026
- July 2026
- Taipei: BIO Asia-Taiwan